Literature DB >> 26631062

Concomitant administration of rifampicin and oxcarbazepine results in a significant decrease of the active MHD metabolite of oxcarbazepine.

Ali Sigaroudi1, Gerd A Kullak-Ublick1, Stefan Weiler2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26631062     DOI： 10.1007/s00228-015-1991-z

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  11 in total

1.  Influence of verapamil on the pharmacokinetics of oxcarbazepine and of the enantiomers of its 10-hydroxy metabolite in healthy volunteers.

Authors:  Natalícia de Jesus Antunes; Lauro Wichert-Ana; Eduardo Barbosa Coelho; Oscar Della Pasqua; Veriano Alexandre Junior; Osvaldo Massaiti Takayanagui; Eduardo Tozatto; Maria Paula Marques; Vera Lucia Lanchote
Journal:  Eur J Clin Pharmacol       Date:  2015-10-30       Impact factor: 2.953

2.  10-Hydroxycarbazepine serum concentration-to-oxcarbazepine dose ratio: influence of age and concomitant antiepileptic drugs.

Authors:  Juan A Armijo; Noelia Vega-Gil; Mehrdad Shushtarian; Javier Adín; José L Herranz
Journal:  Ther Drug Monit       Date:  2005-04       Impact factor: 3.681

3.  AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011.

Authors:  C Hiemke; P Baumann; N Bergemann; A Conca; O Dietmaier; K Egberts; M Fric; M Gerlach; C Greiner; G Gründer; E Haen; U Havemann-Reinecke; E Jaquenoud Sirot; H Kirchherr; G Laux; U C Lutz; T Messer; M J Müller; B Pfuhlmann; B Rambeck; P Riederer; B Schoppek; J Stingl; M Uhr; S Ulrich; R Waschgler; G Zernig
Journal:  Pharmacopsychiatry       Date:  2011-09-27       Impact factor: 5.788

4.  Dose dependent enzyme induction by oxcarbazepine?

Authors:  P N Patsalos; J M Zakrzewska; A A Elyas
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

5.  The metabolism of 14C-oxcarbazepine in man.

Authors:  H Schütz; K F Feldmann; J W Faigle; H P Kriemler; T Winkler
Journal:  Xenobiotica       Date:  1986-08       Impact factor: 1.908

6.  Oxcarbazepine: preclinical anticonvulsant profile and putative mechanisms of action.

Authors:  M Schmutz; F Brugger; C Gentsch; M J McLean; H R Olpe
Journal:  Epilepsia       Date:  1994       Impact factor: 5.864

Review 7.  Pharmacokinetic interactions with rifampicin : clinical relevance.

Authors:  Mikko Niemi; Janne T Backman; Martin F Fromm; Pertti J Neuvonen; Kari T Kivistö
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

8.  A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients.

Authors:  P J McKee; J Blacklaw; G Forrest; R A Gillham; S M Walker; D Connelly; M J Brodie
Journal:  Br J Clin Pharmacol       Date:  1994-01       Impact factor: 4.335

9.  Disposition of the antiepileptic oxcarbazepine and its metabolites in healthy volunteers.

Authors:  M Theisohn; G Heimann
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

10.  The pharmacokinetics of oxcarbazepine and its active metabolite 10-hydroxy-carbazepine in healthy subjects and in epileptic patients treated with phenobarbitone or valproic acid.

Authors:  A Tartara; C A Galimberti; R Manni; R Morini; G Limido; G Gatti; A Bartoli; G Strada; E Perucca
Journal:  Br J Clin Pharmacol       Date:  1993-10       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.